A senior physician at Sheba’s Goldschleger Eye Institute with more than 100 published medical articles, Prof. Ido (Didi) Fabian is a world-renowned expert in ocular tumor treatment, with a particular emphasis on retinoblastoma, lymphoma, and melanoma. Among many other accomplishments, Prof. Fabian founded and leads the Global Retinoblastoma Study Group, co-founded the Asian Retinoblastoma Group, and is the initiator and managing organizer of the ISOO Africa conference – the first meeting of the International Society of Ocular Oncology in Africa.
In addition to his clinical activities, Dr. Fabian serves as an associate professor at the Tel Aviv University School of Medicine as well as the London School of Hygiene & Tropical Medicine, London, UK.
Positions
- Director, Sheba Global Ophthalmology
- Associate professor, Tel Aviv University School of Medicine
- Honorary associate professor, London School of Hygiene & Tropical Medicine
- Committee member, the Global Initiative for Childhood Cancer, the World Health Organization (WHO)
Board Certifications
- Ophtalmology
- Ocular Oncology
Publications
Retinoblastoma in Asia: Clinical presentation and Treatment Outcomes in 2112 patients from 33 countries. Ophthalmology 2023
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. The Lancet Global Health 2022
Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncology 2020